Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, Adriana Yndart & Madhavan Nair. (2019) Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. International Journal of Nanomedicine 14, pages 5541-5554.
Read now
Read now
Articles from other publishers (30)
S. Jankie, S. Singh, N. Laurieri & R. Delgoda. 2024. Pharmacognosy. Pharmacognosy
709
726
.
William P. Flavin, Helia Hosseini, Jeffrey W. Ruberti, H. Pirouz Kavehpour, Christopher C. Giza & Mayumi L. Prins. (2023) Traumatic brain injury and the pathways to cerebral tau accumulation. Frontiers in Neurology 14.
Crossref
Crossref
Sumit Kumar, Sidharth Mehan & Acharan S. Narula. (2022) Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions. Journal of Molecular Medicine 101:1-2, pages 9-49.
Crossref
Crossref
Minqi Chen, Jinyue Liang, Yi Liu, Yayue Liu, Chunxia Zhou, Pengzhi Hong, Yi Zhang & Zhong-Ji Qian. (2023) The Mechanism of Two Benzaldehydes from Aspergillus terreus C23-3 Improve Neuroinflammatory and Neuronal Damage to Delay the Progression of Alzheimer’s Disease. International Journal of Molecular Sciences 24:2, pages 905.
Crossref
Crossref
Yun Wei, Meixia Liu & Dongxin Wang. (2021) The propagation mechanisms of extracellular tau in Alzheimer’s disease. Journal of Neurology 269:3, pages 1164-1181.
Crossref
Crossref
Vaibhav S. Marde, Utkarsha A. Atkare, Shweta V. Gawali, Prerna L. Tiwari, Saurabh P. Badole, Nitu L. Wankhede, Brijesh G. Taksande, Aman B. Upaganlawar, Milind J. Umekar & Mayur B. Kale. (2022) Alzheimer’s disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets. Asian Journal of Psychiatry 68, pages 102961.
Crossref
Crossref
Todd E. Golde. (2022) Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers. Neurotherapeutics 19:1, pages 209-227.
Crossref
Crossref
Chen Li, Ruili Wang, Youyou Zhang, Chunting Hu & Qiaoya Ma. (2021) PIAS3 suppresses damage in an Alzheimer’s disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway. Molecular Medicine 27:1.
Crossref
Crossref
Shaymaa Abdulmalek, Mayada Nasef, Doaa Awad & Mahmoud Balbaa. (2021) Protective Effect of Natural Antioxidant, Curcumin Nanoparticles, and Zinc Oxide Nanoparticles against Type 2 Diabetes-Promoted Hippocampal Neurotoxicity in Rats. Pharmaceutics 13:11, pages 1937.
Crossref
Crossref
Jie Xue, Peng Jia, Dong Zhang & Zhiwen Yao. (2021)
TTP488
ameliorates
NLRP3
‐associated inflammation, viability, apoptosis, and
ROS
production in an Alzheimer's disease cell model by mediating the
JAK1
/
STAT3
/
NFκB
/
IRF3
pathway
. Cell Biochemistry and Function 39:4, pages 555-561.
Crossref
Crossref
Ying Han, Le Chen, Yu Guo, Chunyang Wang, Chenghong Zhang, Li Kong & Haiying Ma. (2021) Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo. Frontiers in Aging Neuroscience 12.
Crossref
Crossref
Wei Chen, Lin Wu, Yueqiang Hu, Lingfei Jiang, Ni Liang, Jing Chen, Hongling Qin & Nong Tang. (2020) MicroRNA-107 Ameliorates Damage in a Cell Model of Alzheimer’s Disease by Mediating the FGF7/FGFR2/PI3K/Akt Pathway. Journal of Molecular Neuroscience 70:10, pages 1589-1597.
Crossref
Crossref
Botond Penke, Mária Szűcs & Ferenc Bogár. (2020) Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis. Molecules 25:7, pages 1659.
Crossref
Crossref
Jiqing Cao, Margaret B. Zhong, Carlos A. Toro, Larry Zhang & Dongming Cai. (2019) Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis. Neuroscience Letters 703, pages 68-78.
Crossref
Crossref
Cheril Tapia-Rojas, Fabian Cabezas-Opazo, Carol A. Deaton, Erick H. Vergara, Gail V.W. Johnson & Rodrigo A. Quintanilla. (2019) It’s all about tau. Progress in Neurobiology 175, pages 54-76.
Crossref
Crossref
Nadia I. Bocai, María S. Marcora, Lautaro F. Belfiori-Carrasco, Laura Morelli & Eduardo M. Castaño. (2019) Endoplasmic Reticulum Stress in Tauopathies: Contrasting Human Brain Pathology with Cellular and Animal Models. Journal of Alzheimer's Disease 68:2, pages 439-458.
Crossref
Crossref
Yanping Zhu, Xiaoyang Shan, Farzaneh Safarpour, Nancy Erro Go, Nancy Li, Alice Shan, Mina C. Huang, Matthew Deen, Viktor Holicek, Roger Ashmus, Zarina Madden, Sharon Gorski, Michael A. Silverman & David J. Vocadlo. (2018) Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway. ACS Chemical Neuroscience 9:6, pages 1366-1379.
Crossref
Crossref
Cristina CariuloLucia AzzolliniMargherita VeraniPaola MartufiRoberto BoggioAnass ChikiSean M. DeguireMarta CherubiniSilvia GinesJ. Lawrence MarshPaola ConfortiElena CattaneoIolanda Santimone, Ferdinando Squitieri, Hilal A. LashuelLara PetriccaAndrea Caricasole. (2017) Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation. Proceedings of the National Academy of Sciences 114:50.
Crossref
Crossref
Qian-Qian Ouyang, Shannon Zhao, Si-Dong Li & Cai Song. (2017) Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer’s Disease. Marine Drugs 15:11, pages 322.
Crossref
Crossref
Dae Young Yoo, Dae Won Kim, Hyun Jung Kwon, Hyo Young Jung, Sung Min Nam, Jong Whi Kim, Jin Young Chung, Moo-Ho Won, Yeo Sung Yoon, Soo Young Choi & In Koo Hwang. (2017) Chronic administration of SUMO-1 has negative effects on novel object recognition memory as well as cell proliferation and neuroblast differentiation in the mouse dentate gyrus. Molecular Medicine Reports 16:3, pages 3427-3432.
Crossref
Crossref
N. Laurieri & R. Delgoda. 2017. Pharmacognosy. Pharmacognosy
617
632
.
Mansi R. Khanna, Jane Kovalevich, Virginia M.‐Y. Lee, John Q. Trojanowski & Kurt R. Brunden. (2016) Therapeutic strategies for the treatment of tauopathies: Hopes and challenges. Alzheimer's & Dementia 12:10, pages 1051-1065.
Crossref
Crossref
Feng Bai, Wei Liao, Chunxian Yue, Mengjia Pu, Yongmei Shi, Hui Yu, Yonggui Yuan, Leiyu Geng & Zhijun Zhang. (2014) Genetics pathway-based imaging approaches in Chinese Han population with Alzheimer?s disease risk. Brain Structure and Function 221:1, pages 433-446.
Crossref
Crossref
Masafumi Shimojo, Makoto Higuchi, Tetsuya Suhara & Naruhiko Sahara. (2015) Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging. Frontiers in Neuroscience 9.
Crossref
Crossref
C. Geeth Gunawardana, Mohadeseh Mehrabian, Xinzhu Wang, Iris Mueller, Isabela B. Lubambo, James E.N. Jonkman, Hansen Wang & Gerold Schmitt-Ulms. (2015) The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome. Molecular & Cellular Proteomics 14:11, pages 3000-3014.
Crossref
Crossref
Robert Nisticò, Caterina Ferraina, Veronica Marconi, Fabio Blandini, Lucia Negri, Jan Egebjerg & Marco Feligioni. (2014) Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease. Frontiers in Pharmacology 5.
Crossref
Crossref
Danielle L. Graham, Audrey J. Gray, John A. Joyce, Dongzi Yu, Jill O'Moore, George A. Carlson, Mark S. Shearman, Tammy L. Dellovade & Heike Hering. (2014) Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology 79, pages 307-313.
Crossref
Crossref
Carlos Cruchaga, John S.K. Kauwe, Oscar Harari, Sheng Chih Jin, Yefei Cai, Celeste M. Karch, Bruno A. Benitez, Amanda T. Jeng, Tara Skorupa, David Carrell, Sarah Bertelsen, Matthew Bailey, David McKean, Joshua M. Shulman, Philip L. De Jager, Lori Chibnik, David A. Bennett, Steve E. Arnold, Denise Harold, Rebecca Sims, Amy Gerrish, Julie Williams, Vivianna M. Van Deerlin, Virginia M.-Y. Lee, Leslie M. Shaw, John Q. Trojanowski, Jonathan L. Haines, Richard Mayeux, Margaret A. Pericak-Vance, Lindsay A. Farrer, Gerard D. Schellenberg, Elaine R. Peskind, Douglas Galasko, Anne M. Fagan, David M. Holtzman, John C. Morris & Alison M. Goate. (2013) GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease. Neuron 78:2, pages 256-268.
Crossref
Crossref
Melvyn J. Ball, Walter J. Lukiw, Eli M. Kammerman & James M. Hill. (2012) Intracerebral propagation of Alzheimer's disease: Strengthening evidence of a herpes simplex virus etiology. Alzheimer's & Dementia 9:2, pages 169-175.
Crossref
Crossref
Scott A Yuzwa, Xiaoyang Shan, Matthew S Macauley, Thomas Clark, Yuliya Skorobogatko, Keith Vosseller & David J Vocadlo. (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nature Chemical Biology 8:4, pages 393-399.
Crossref
Crossref